NII Holdings Inc (NASDAQ:NIHD) is going to rent a network space from Telefonica Brasil SA. The rent deal is valued around $472 million. The rent deal will be applicable for a period of five years. Telefonica is the largest wireless carrier in Brazil. NII Holdings Inc. (NASDAQ:NIHD) net profit margin is -41.20% and weekly performance is -8.20%. On last trading day company shares ended up $0.560. Analysts mean target price for the company is $2.13. NII Holdings Inc. (NASDAQ:NIHD) distance from 50-day simple moving average (SMA50) is -40.73%.
LINN Energy, LLC (NASDAQ:LINE) and LinnCo, LLC (Nasdaq:LNCO) announced that LINN has signed a definitive agreement to trade a portion of its Permian Basin properties to Exxon Mobil Corporation (NYSE:XOM) and its wholly owned subsidiary XTO Energy Inc. (collectively, “ExxonMobil”) for operating interests in the Hugoton Basin. The transaction is expected to close in the third quarter of 2014 with an effective date of June 1, 2014. Linn Energy LLC (NASDAQ:LINE) shares advanced 0.67% in last trading session and ended the day on $28.48. LINE gross Margin is 82.30% and its return on assets is -5.60%.Linn Energy LLC (NASDAQ:LINE) quarterly performance is -12.48%.
Sony Corp. (ADR) (NYSE:SNE) Chief Executive Kazuo Hirai said Thursday the company accumulated huge losses because it didn’t respond quickly enough to changing market conditions, but promised a return to profit next year. Sony Corp (ADR) (NYSE:SNE) shares moved up 0.81% in last trading session and was closed at $16.18, while trading in range of $16.16 – $16.37. Sony Corp (ADR) (NYSE:SNE) year to date (YTD) performance is -6.42%.
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) shares gained 6%. Results for several clinical trials of Kalydeco are expected soon and could have an impact on the stock, said analyst Geoff Porges at Bernstein Research in his Biotech Catalyst Monitor Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ended the last trading day at $71.18. Company weekly volatility is calculated as 4.22% and price to cash ratio as 11.47.Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) showed a positive weekly performance of 8.74%.
Dendreon Corporation (NASDAQ:DNDN) announced that it presented data from the ProACT and IMPACT studies on Provenge at the annual meeting of the American Urological Association (AUA). Dendreon’s shares gained around 8% following the announcement. Dendreon Corporation (NASDAQ:DNDN) weekly performance is 4.78%. On last trading day company shares ended up $2.19. Analysts mean target price for the company is $2.41. Dendreon Corporation (NASDAQ:DNDN) distance from 50-day simple moving average (SMA50) is -17.42%.